Literature DB >> 1892365

Benefits of monitoring plasma levodopa in Parkinson's disease patients with drug-induced chorea.

J I Sage1, M H Mark, D M McHale, P K Sonsalla, D Vitagliano.   

Abstract

We studied the temporal patterns of chorea and plasma levodopa profiles in 30 patients with Parkinson's disease whose motor fluctuations were difficult to characterize and treat on the basis of observation alone. We were able to determine whether chorea was associated with high levodopa concentrations or low levodopa concentrations or both. We found the following patterns of levodopa-associated chorea: chorea due to inadequate levodopa levels, chorea due to biphasic levodopa absorption, chorea associated with either rapid or slow levodopa absorption, and chorea due to long-duration levodopa absorption mimicking a sustained-release preparation. Seven patients benefited after their dosing schedules were rearranged as a result of information gained from monitoring. We conclude that any patient with levodopa-associated chorea who cannot be regulated on the basis of observation alone should be studied with simultaneous plasma levodopa measurements and clinical monitoring to detect an unusual plasma levodopa pattern that may be improved by adjustment of dosing schedule.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1892365     DOI: 10.1002/ana.410290609

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  4 in total

Review 1.  Drug-induced movement disorders.

Authors:  F J Jiménez-Jiménez; P J García-Ruiz; J A Molina
Journal:  Drug Saf       Date:  1997-03       Impact factor: 5.606

2.  Periodic Limb Movements while Awake (PLMA) as a Manifestation of Wearing-Off in Parkinson's Disease: A Case Series and Review of the Literature.

Authors:  Sohaila Alshimemeri; Daniel G Di Luca; Diana A Olszewska; Eoin Mulroy; Kailash P Bhatia; Susan H Fox; Anthony E Lang
Journal:  Mov Disord Clin Pract       Date:  2022-06-10

Review 3.  Pharmacokinetic optimisation in the treatment of Parkinson's disease.

Authors:  M Contin; R Riva; F Albani; A Baruzzi
Journal:  Clin Pharmacokinet       Date:  1996-06       Impact factor: 6.447

4.  Wearable Electrochemical Sensors in Parkinson's Disease.

Authors:  Francesco Asci; Giorgio Vivacqua; Alessandro Zampogna; Valentina D'Onofrio; Adolfo Mazzeo; Antonio Suppa
Journal:  Sensors (Basel)       Date:  2022-01-26       Impact factor: 3.576

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.